Compounds > chloroquine

chloroquine and 2-anthramine

chloroquine has been researched along with 2-anthramine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Amewu, R; Bongard, E; Charnaud, S; Davies, J; Ellis, GL; Gargallo, D; Gibbons, P; Hall, C; Jesús, M; Lozanom, S; O'Neill, PM; Rimmer, K; Sabbani, S; Shone, A; Stanford, D; Stocks, PA; Vivas, L; Ward, SA1
Berry, P; Campo, B; Cao, J; Ciaravino, V; Easom, EE; Erve, JCL; Freund, YR; Gamo, FJ; Guo, D; Jacobs, RT; Plattner, JJ; Rosenthal, PJ; Sanz, LM; Zhang, YK1
Chan, SSL; Chou, CJ; Dolloff, N; Halene, S; Himes, RA; Inks, ES; Jiang, Y; Li, X; Luo, X; Peterson, YK; Xu, T; Yin, G1

Other Studies

3 other study(ies) available for chloroquine and 2-anthramine

ArticleYear
Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles.
    Journal of medicinal chemistry, 2008, Apr-10, Volume: 51, Issue:7

    Topics: Animals; Antimalarials; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Salmonella typhimurium; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Tetraoxanes

2008
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
    Journal of medicinal chemistry, 2017, 07-13, Volume: 60, Issue:13

    Topics: Amides; Animals; Antimalarials; Boron Compounds; Dogs; Female; Humans; Malaria; Malaria, Falciparum; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2017
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.
    Journal of medicinal chemistry, 2020, 05-28, Volume: 63, Issue:10

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Leukemia, Myeloid, Acute; Male; Mice; Panobinostat; Tumor Suppressor Protein p53

2020